ADA's program allows for inclusion of later submissions of newly completed research and clinical trials. The abstract should describe a noteworthy and timely research advance that has not been previously published or submitted. Submissions will be accepted until Monday, March 16, 5:00 p.m. ET. View the submission guidelines.
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.